HKSH’s IVF Centre First in Hong Kong to Apply Next Generation Sequencing (NGS) to Pre-implantation Genetic Testing – Helps Infertile Couples Enhance Pregnancy Rate and Reduces the Chance of Transmitting Genetic Abnormality from Parents to Their Offspring

(27 July 2016, Hong Kong) The IVF Centre of Hong Kong Sanatorium & Hospital (“the Hospital”) has always been at the technological forefront to assist couples with infertility issues since the birth of Hong Kong’s first in vitro fertilization (IVF) baby at the Centre in 1986. In its latest initiative, the Centre has applied advanced genomic technology, Next Generation Sequencing (NGS), to pre-implantation genetic testing. Pre-implantation Genetic Screening (PGS) and Pre-implantation Genetic Diagnosis (PGD) with sophisticated NGS technology facilitate embryo selection, which in turn help enhance pregnancy rate and decrease the potential hazard of transmitting a genetic abnormality or disease from parents to their offspring.

Please click here for more information.

慎防诈骗提示：近日接获有公众人士指称收到冒充养和医院的电话，并通知有医疗文件未领取，此类通讯均为冒充来电，切勿回覆或提供个人资料。公众人士请慎防冒充养和医疗集团或其成员包括养和医院、养和医健、养和东区医疗中心、养和癌症中心以及各关联公司名义的通讯 (虚假网站、电邮或语音来电等)。如有怀疑，切勿提供个人资料，并致电2572 0211与本集团联络。

山村园地

桌面版

语言

最新消息

HKSH’s IVF Centre First in Hong Kong to Apply Next Generation Sequencing (NGS) to Pre-implantation Genetic Testing – Helps Infertile Couples Enhance Pregnancy Rate and Reduces the Chance of Transmitting Genetic Abnormality from Parents to Their Offspring

语言

搜索表单

最新消息

HKSH’s IVF Centre First in Hong Kong to Apply Next Generation Sequencing (NGS) to Pre-implantation Genetic Testing – Helps Infertile Couples Enhance Pregnancy Rate and Reduces the Chance of Transmitting Genetic Abnormality from Parents to Their Offspring